A detailed history of First Trust Advisors LP transactions in Exact Sciences Corp stock. As of the latest transaction made, First Trust Advisors LP holds 802,767 shares of EXAS stock, worth $39.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
802,767
Previous 827,621 3.0%
Holding current value
$39.7 Million
Previous $56.4 Million 19.95%
% of portfolio
0.04%
Previous 0.06%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$49.33 - $71.97 $1.23 Million - $1.79 Million
-24,854 Reduced 3.0%
802,767 $45.1 Million
Q3 2024

Nov 13, 2024

BUY
$42.43 - $70.83 $13.5 Million - $22.6 Million
318,710 Added 62.63%
827,621 $56.4 Million
Q2 2024

Aug 13, 2024

SELL
$41.33 - $74.26 $14.1 Million - $25.4 Million
-342,045 Reduced 40.2%
508,911 $21.5 Million
Q1 2024

May 13, 2024

SELL
$56.27 - $73.77 $2.34 Million - $3.07 Million
-41,668 Reduced 4.67%
850,956 $58.8 Million
Q4 2023

Feb 13, 2024

SELL
$59.06 - $75.72 $2.16 Million - $2.77 Million
-36,580 Reduced 3.94%
892,624 $66 Million
Q3 2023

Nov 13, 2023

SELL
$65.94 - $99.04 $23.2 Million - $34.8 Million
-351,592 Reduced 27.45%
929,204 $63.4 Million
Q2 2023

Aug 14, 2023

SELL
$62.68 - $95.05 $3.26 Million - $4.94 Million
-52,008 Reduced 3.9%
1,280,796 $120 Million
Q1 2023

May 15, 2023

SELL
$47.19 - $70.77 $416,451 - $624,545
-8,825 Reduced 0.66%
1,332,804 $90.4 Million
Q4 2022

Feb 09, 2023

BUY
$30.35 - $53.15 $12 Million - $21 Million
395,660 Added 41.83%
1,341,629 $66.4 Million
Q3 2022

Nov 14, 2022

BUY
$31.97 - $49.37 $8.03 Million - $12.4 Million
251,091 Added 36.13%
945,969 $30.7 Million
Q2 2022

Aug 12, 2022

SELL
$35.61 - $76.23 $201,695 - $431,766
-5,664 Reduced 0.81%
694,878 $27.4 Million
Q1 2022

May 13, 2022

BUY
$57.56 - $82.54 $5.72 Million - $8.21 Million
99,441 Added 16.54%
700,542 $49 Million
Q4 2021

Feb 08, 2022

BUY
$72.5 - $100.68 $2.5 Million - $3.47 Million
34,504 Added 6.09%
601,101 $46.8 Million
Q3 2021

Nov 15, 2021

SELL
$90.24 - $124.05 $19 Million - $26.2 Million
-210,861 Reduced 27.12%
566,597 $54.1 Million
Q2 2021

Aug 16, 2021

SELL
$93.66 - $139.27 $6.44 Million - $9.58 Million
-68,769 Reduced 8.13%
777,458 $96.6 Million
Q1 2021

May 14, 2021

SELL
$116.57 - $155.01 $23 Million - $30.6 Million
-197,111 Reduced 18.89%
846,227 $112 Million
Q4 2020

Feb 02, 2021

BUY
$99.61 - $142.12 $11.4 Million - $16.2 Million
114,087 Added 12.28%
1,043,338 $138 Million
Q3 2020

Nov 05, 2020

BUY
$72.92 - $102.01 $3.76 Million - $5.27 Million
51,629 Added 5.88%
929,251 $94.7 Million
Q2 2020

Jul 22, 2020

BUY
$55.75 - $92.75 $6.89 Million - $11.5 Million
123,600 Added 16.39%
877,622 $76.3 Million
Q1 2020

May 06, 2020

BUY
$37.9 - $104.44 $6.81 Million - $18.8 Million
179,725 Added 31.29%
754,022 $43.7 Million
Q4 2019

Feb 03, 2020

SELL
$77.66 - $99.74 $23.9 Million - $30.7 Million
-307,761 Reduced 34.89%
574,297 $53.1 Million
Q3 2019

Nov 04, 2019

SELL
$90.37 - $122.49 $59.1 Million - $80.1 Million
-653,722 Reduced 42.57%
882,058 $79.7 Million
Q2 2019

Jul 30, 2019

BUY
$89.51 - $118.04 $94.7 Million - $125 Million
1,057,434 Added 221.06%
1,535,780 $181 Million
Q1 2019

May 09, 2019

SELL
$61.98 - $96.5 $18 Million - $28 Million
-290,299 Reduced 37.77%
478,346 $41.4 Million
Q4 2018

Feb 07, 2019

BUY
$56.04 - $82.66 $13.7 Million - $20.2 Million
243,901 Added 46.48%
768,645 $48.5 Million
Q3 2018

Oct 25, 2018

BUY
$48.29 - $80.6 $24.9 Million - $41.6 Million
516,442 Added 6220.69%
524,744 $41.4 Million
Q2 2018

Aug 02, 2018

SELL
$37.84 - $69.96 $2.77 Million - $5.12 Million
-73,225 Reduced 89.82%
8,302 $496,000
Q1 2018

Apr 23, 2018

BUY
$39.82 - $57.53 $127,384 - $184,038
3,199 Added 4.08%
81,527 $3.29 Million
Q4 2017

Feb 08, 2018

BUY
$46.49 - $60.51 $447,698 - $582,711
9,630 Added 14.02%
78,328 $4.12 Million
Q3 2017

Oct 24, 2017

BUY
$37.05 - $47.12 $2.55 Million - $3.24 Million
68,698
68,698 $3.24 Million

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $8.76B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track First Trust Advisors LP Portfolio

Follow First Trust Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Trust Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on First Trust Advisors LP with notifications on news.